Rothschild Investment LLC Innoviva, Inc. Transaction History

Rothschild Investment LLC

$1.44 Trillion
Q2 2024

A detailed history of Rothschild Investment LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 30 shares of INVA stock, worth $586. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$586

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 30, 2024	BUY	$14.4 - $16.4 $432 - $491	30 New	30 $492,000
Q1 2024 Jul 31, 2024	SELL	$14.56 - $16.78 $291 - $335	-20 Reduced 66.67%	10 $152,000

Others Institutions Holding INVA

# of Institutions

222

Shares Held

79.7M

Call Options Held

20K

Put Options Held

5.4K

Black Rock Inc. New York, NY

9.63M
Shares

$188 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

7.28M
Shares

$142 Million
20.14% of portfolio
Franklin Resources Inc San Mateo, CA

6.62M
Shares

$129 Million
0.03% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$123 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

6.18M
Shares

$121 Million
0.0% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.36B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.

Account